Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for TFX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.905B
March 31, 2026 3.084B
December 31, 2025 3.125B
September 30, 2025 3.822B
June 30, 2025 4.243B
March 31, 2025 4.095B
December 31, 2024 4.278B
September 30, 2024 4.482B
June 30, 2024 4.559B
March 31, 2024 4.503B
December 31, 2023 4.441B
September 30, 2023 4.314B
June 30, 2023 4.215B
March 31, 2023 4.110B
December 31, 2022 4.022B
September 30, 2022 3.895B
June 30, 2022 3.853B
March 31, 2022 3.796B
December 31, 2021 3.755B
September 30, 2021 3.658B
June 30, 2021 3.466B
March 31, 2021 3.376B
December 31, 2020 3.336B
September 30, 2020 3.236B
June 30, 2020 3.097B
Date Value
March 31, 2020 3.073B
December 31, 2019 2.979B
September 30, 2019 2.853B
June 30, 2019 2.665B
March 31, 2019 2.570B
December 31, 2018 2.540B
September 30, 2018 2.507B
June 30, 2018 2.434B
March 31, 2018 2.560B
December 31, 2017 2.431B
September 30, 2017 2.472B
June 30, 2017 2.359B
March 31, 2017 2.219B
December 31, 2016 2.138B
September 30, 2016 2.170B
June 30, 2016 2.119B
March 31, 2016 2.059B
December 31, 2015 2.009B
September 30, 2015 1.939B
June 30, 2015 1.918B
March 31, 2015 1.858B
December 31, 2014 1.911B
September 30, 2014 1.982B
June 30, 2014 1.982B
March 31, 2014 1.942B

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 4.769B
Boston Scientific Corp. 24.93B
Alphatec Holdings, Inc. 11.53M
CONMED Corp. 1.041B
DexCom, Inc. 2.621B

Shareholders Equity (Quarterly) Related Metrics